ZBIOZenas BioPharma Inc. Common Stock
32.29USD+3.33%Mkt Cap: 2.10B $P/E: —3d ago
Zenas BioPharma, Inc., a clinical-stage biopharma company, engages in the development and commercialization of transformative immunology-based therapies. Its lead product candidate is obexelimab, a bifunctional monoclona…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap2.10B $
Enterprise Value1.72B $
Revenue (TTM)1.00M $
Gross Profit-212.47M $
Net Income (TTM)-377.74M $
Revenue/Share0.0190 USD
Last Price32.29 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees167
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-6.79
PEG—
EV/EBITDA-6.26
EV/Revenue1715.62
P/S2060.89
P/B8.10
EPS (TTM)-9.76
EPS (Forward)-4.66
52W Range
13.5060% of range44.60
52W High44.60 USD
52W Low13.50 USD
Profitability
Gross Margin0.00%
Oper. Margin-7765.90%
EBITDA Margin0.00%
Profit Margin-3777.37%
ROE-156.00%
ROA-98.46%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-172.33M $
CapEx (TTM)35.02M $
FCF Margin-21139.16%
FCF Yield-10.04%
Net Debt-345.27M $
Net Debt/EBITDA1.26
Balance Sheet
Debt/Equity0.01
Current Ratio9.93
Quick Ratio9.78
Book Value/Sh3.902 USD
Cash/Share9.867 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)47.00 USD
Upside (mean)+45.6%
Target Range32.00 USD – 59.00 USD
$32.00+45.6% to mean$59.00
# Analysts8
Ownership
Shares Out.65.18M
Float43.11M
Insiders16.69%
Institutions93.13%
Short Interest
Short Ratio13.0d
Short % Float27.75%
Short % Out.18.62%
Shares Short11.75M
Short (prev mo.)12.20M
Technical
SMA 5027.79 (+16.2%)
SMA 20026.04 (+24.0%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)761.24K
Avg Vol (10d)874.36K
Technical Indicators
RSI (14)59.1
MACD0.8273
MACD Signal1.1658
MACD Hist.-0.3386
BB Upper33.40 USD
BB Middle31.44 USD
BB Lower29.48 USD
BB Width12.47%
ATR (14)1.937 USD
Vol Ratio (20d)1.03x